25-hydroxyvitamin D: Clinical Trials

5 trials of 25-hydroxyvitamin D, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 2 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 21Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow 25-hydroxyvitamin D: new trials by email Literature Review of 25-hydroxyvitamin D trials Research Report on 25-hydroxyvitamin D

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial
placebo Oil, 25-Hydroxyvitamin D - HIV-1-infection, Hypovitaminosis D
Phase 3CompletedUniversity of the Punjab952019-02-152022-04-11
The Effect of Vitamin D Supplementation on Psoriasis Severity
25-Hydroxyvitamin D, Placebo oral capsule - Psoriasis, Vitamin D Deficiency
Not applicableCompletedUniversity Hospital of North Norway1152017-11-242020-10-08
To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With Osteopenia
Calcifediol, Vitamin D3, Placebo - Osteopenia/Osteoporosis
Phase 2Completeddsm-firmenich Switzerland AG1502015-09-012019-04-30
Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults
vitamin D3, 25-hydroxyvitamin D3, 25-hydroxyvitamin D (20 microgram/day) - Vitamin D Status as Reflected by Serum 25-hydroxyvitamin D
Not applicableCompletedUniversity College Cork562011-01-012015-12-02
Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients
Structured Exercise program, Cholecalciferol (25-Hydroxyvitamin D), Usual exercise - End Stage Kidney Disease
Phase 4CompletedSir Charles Gairdner Hospital192009-01-012013-06-10

Conditions studied

Vitamin D Deficiency (2)  ·  Bone Diseases, Metabolic (1)  ·  Kidney Failure, Chronic (1)  ·  Motor Activity (1)  ·  Psoriasis (1)

Sponsors

Sir Charles Gairdner Hospital (1)  ·  University College Cork (1)  ·  University Hospital of North Norway (1)  ·  University of the Punjab (1)  ·  dsm-firmenich Switzerland AG (1)

Countries

Australia (1)  ·  Ireland (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Switzerland (1)

Top investigators

Ben Bull (1)  ·  Heike Bischoff-Ferrari, Prof, Dr.PH (1)  ·  Kevin D Cashman, PhD (1)  ·  Kjersti Danielsen, MD, PhD (1)  ·  Neil Boudville (1)

Results publications

PMID 22552038, PMID 36385193, PMID 36988936, PMID 40205202

NIH funding

2016 (1)